Platform Technology Partners Compugen LTD Transaction History
Platform Technology Partners
- $385 Million
- Q3 2025
A detailed history of Platform Technology Partners transactions in Compugen LTD stock. As of the latest transaction made, Platform Technology Partners holds 10,000 shares of CGEN stock, worth $16,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$16,800% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CGEN
# of Institutions
79Shares Held
16.3MCall Options Held
59.3KPut Options Held
32.1K-
Silverarc Capital Management, LLC3.03MShares$5.1 Million1.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.33MShares$2.23 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.31MShares$2.21 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.07MShares$1.8 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.71 Million0.0% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $146M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...